The Study of Polycystic Ovary Syndrome (PCOS) and Questionnaire
|ClinicalTrials.gov Identifier: NCT01256970|
Recruitment Status : Completed
First Posted : December 9, 2010
Last Update Posted : September 11, 2013
|Condition or disease|
|Polycystic Ovary Syndrome|
|Study Type :||Observational|
|Actual Enrollment :||306 participants|
|Official Title:||The Study of Polycystic Ovary Syndrome (PCOS) and Questionnaire|
|Study Start Date :||November 2010|
|Primary Completion Date :||January 2013|
|Study Completion Date :||January 2013|
Polycystic Ovary Syndrome.
Polycystic ovary syndrome was diagnosed according to the 2003 Rotterdam criteria, which require a minimum of two of the following three criteria: PCOM, chronic anovulation and hyperandrogenism.
Normal control women were women who did not present with any of three PCOS criteria.
- Obesity is the predominant predictor of impaired glucose tolerance and metabolic disturbance in polycystic ovary syndrome. [ Time Frame: Prospectively study in University teaching hospital from 31 August 2010 to 31 August 2011. ]To evaluate the contribution to glucose intolerance and metabolic syndrome of obesity combined with the diagnostic criteria of polycystic ovary syndrome (PCOS).
Biospecimen Retention: Samples Without DNA
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01256970
|Taipei Medical University-WanFang Hospital|
|Principal Investigator:||Ming-I Hsu||Taipei Medical University WanFang Hospital|